APA (7th ed.) Citation

Spiers, L., Gray, M., Lyon, P., Sivakumar, S., Bekkali, N., Scott, S., . . . Coussios, C. (2023). Clinical trial protocol for PanDox: A phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasound. BioMed Central.

Chicago Style (17th ed.) Citation

Spiers, L., et al. Clinical Trial Protocol for PanDox: A Phase I Study of Targeted Chemotherapy Delivery to Non-resectable Primary Pancreatic Tumours Using Thermosensitive Liposomal Doxorubicin (ThermoDox®) and Focused Ultrasound. BioMed Central, 2023.

MLA (9th ed.) Citation

Spiers, L., et al. Clinical Trial Protocol for PanDox: A Phase I Study of Targeted Chemotherapy Delivery to Non-resectable Primary Pancreatic Tumours Using Thermosensitive Liposomal Doxorubicin (ThermoDox®) and Focused Ultrasound. BioMed Central, 2023.